FEMALE COUNSELING AS AN IMPORTANT TOOL WHEN INDIVIDUALLY CHOOSING A CONTRACEPTIVE METHOD


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Based of the data available in the Russian and foreign literature and statistical data, the author considers the issues of preservation of reproductive health in the population and those of increasing birth rate. Reasons for high abortion rates in the country are identif ied. There is evidence for the use of combined oral contraceptives as a main tool to reduce abortions. The paper shows it necessary to introduce counseling when prescribing hormonal contraceptive agents. Basic counseling steps are disclosed.

Texto integral

Acesso é fechado

Sobre autores

I. ALESINA

Effective Information and Health Center

Email: ceih@bk.ru

Bibliografia

  1. Госкомстат РФ. — М., 2009.
  2. Критерии приемлемости использования методов контрацепции. — Женева: ВОЗ, 2009.
  3. Кулаков В.И., Серов В.Н., Ваганов Н.Н., Прилепская В.Н. Руководство по планированию семьи. — М., 1997.
  4. Ромащенко О.В., Мельников С.Н., Билоголовская В.В. Состояние сексуального здоровья женщины на фоне применения гормональной контрацепции // Акуш. и гин. — 2007. — № 6. — С. 64—67.
  5. Пособие по консультированию «ПОМОГИ». — Факультет охраны здоровья ун-та им. Дж. Хопкинса. — Центр коммуникативных программ, 1998.
  6. Руководство по контрацепции/ Под ред. В.Н. Прилепской. — М.: МЕДпресс-информ, 2010.
  7. Универсальное руководство для поставщиков услуг по планированию семьи. — ВОЗ. Ун-т им. Дж. Хопкинса. — Центр коммуникативных программ, 2008.
  8. Arowojulu A.O., Gallo M.F., Lopez L.M. et al. Combined oral contraceptive pills for treatment of acne // Cochrane Database Syst. Rev. — 2004. — № 3. — P. 64—67.
  9. Batukan C., Muderris I.I. Efficacy of a new oral contraceptive containing drospirenone and ethinyl in the long-term treatment of hirsutism. Erciyes University, School of Medicine of Obstetrics and Gynecology, Kayseri, Turkey // Fertil. and Steril. — 2006. — Vol. 85, № 2. — P. 436.
  10. Gallo M.F., Lopez L.M., Grimes D.A. et al. Combination contraceptives: effects on weight. (Cochrane Review) // The Cochrane Library. — Issue 1. — Oxford: Update Software, 2006.
  11. Huber J., Foidart J.M., Wuttke W. et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone // Eur. J. Contracept. Reprod. Hlth Care. — 2000. — Vol. 5. — Р. 25—34.
  12. Lopez L.M., Kaptein A.A., Helmerhorse F.M. Oral contraceptives containing drospirenone for premenstrual syndrome // Cochrane Database Syst. Rev. — 2009. —№ 1. — CD007249.
  13. Pariani S., Heer D.M., Arsdol M.D. Does choice make a difference to contraceptive use? Evidence from East Java // Stud. Family Planning. — 1992. — Vol. 22, № 6. — P. 384—390.
  14. WHO. Medical eligibility criteria for contraceptive use. — 4th ed. — Geneva, 2009.
  15. WHO. Selected practice recommendation for contraceptive use. — 2nd ed. Geneva, 2005.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2011

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies